77
Participants
Start Date
September 28, 2022
Primary Completion Date
February 12, 2024
Study Completion Date
May 6, 2024
EYP-1901
EYP-1901 will be administered to the study eye by a single injection through the pars plana using a pre-loaded applicator with a 22-gauge needle. Each EYP-1901 IVT insert has been designed to deliver vorolanib into the vitreous humor for approximately 6 to 9 months.
Sham IVT
Sham injections will be used to maintain masking of investigational EYP-1901 therapy for study subjects.
EyePoint Investigative Site, Great Neck
EyePoint Investigative Site, Erie
EyePoint Investigative Site, Baltimore
EyePoint Investigative Site, Hagerstown
EyePoint Investigative Site, Lynchburg
EyePoint Investigative Site, Ladson
EyePoint Investigative Site, Florence
EyePoint Investigative Site, Melbourne
EyePoint Investigative Site, Miami
EyePoint Investigative Site, Clearwater
EyePoint Investigative Site, Winter Haven
EyePoint Investigative Site, Germantown
EyePoint Investigative Site, Indianapolis
EyePoint Investigative Site, Rapid City
EyePoint Investigative Site, Lemont
EyePoint Investigative Site, Lenexa
EyePoint Investigative Site, Plano
EyePoint Investigative Site, The Woodlands
EyePoint Investigative Site, Houston
EyePoint Investigative Site, San Antonio
EyePoint Investigative Site, McAllen
EyePoint Investigative Site, Austin
EyePoint Investigative Site, Abilene
EyePoint Investigative Site, Phoenix
EyePoint Investigative Site, Reno
EyePoint Investigative Site, Pasadena
EyePoint Investigative Site, Poway
EyePoint Investigative Site, Palm Desert
EyePoint Investigative Site, Huntington Beach
EyePoint Investigative Site, Oxnard
EyePoint Investigative Site, Sacramento
EyePoint Investigative Site, Bellevue
EyePoint Investigative Site, Danbury
EyePoint Investigative Site, Springfield
EyePoint Investigative Site, Bloomfield
EyePoint Investigative Site, Toms River
Lead Sponsor
EyePoint Pharmaceuticals, Inc.
INDUSTRY